Interestingly, these chemokines and/or their respective receptors have been observed to be elevated in MS patients [35], suggesting that Lb-associated molecular patterns result in TLR2-dependent tolerance of a clinically relevant pathway. This evidence concerns the gene TLR2 and myeloid sarcoma.